A Novel 14-Gene Panel Associated With Efferocytosis for Predicting Pancreatic Cancer Prognosis Through Bulk and Single-Cell Databases
Our findings underscore the importance of considering a novel prognostic signature comprising 14 ER genes in the context of the TME when investigating the biology of PDAC. Future studies may explore how modulating these interactions could lead to novel therapeutic opportunities.
Authors
- Chun‐Xiang Ye (ORCID: https://orcid.org/0000-0001-7015-3166)
- Wei Zhao (ORCID: https://orcid.org/0000-0001-6732-9466)
- Jingtao Liu (ORCID: https://orcid.org/0000-0002-3340-5958)
- Yi Dong (ORCID: https://orcid.org/0000-0003-3047-7777)
- Bin Dong (ORCID: https://orcid.org/0000-0002-4284-8566)
- Lin Zhao
- Zhihua Tian
- Ying‐Tai Wu
- Huachong Ma (ORCID: https://orcid.org/0009-0005-0257-5793)
Institutions
- Peking University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- Peking University Cancer Hospital (CN)
- Beijing Luhe Hospital Affiliated to Capital Medical University (CN)
- Ministry of Education (ET)
- Beijing Chaoyang Emergency Medical Center (CN)
- Beijing University of Chemical Technology (CN)
- University of Science and Technology Beijing (CN)
Publication Details
- Journal
- Frontiers in Bioscience-Landmark
- Published
- 2025-07-30
- DOI
- https://doi.org/10.31083/fbl40818
- Primary Topic
- Phagocytosis and Immune Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China